Mycophenolic Acid Induces Osteogenesis in Tonsil-Derived Mesenchymal Stem Cells through Inhibition of IMPDH and HDAC3
- 23 October 2025
- journal article
- research article
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 22 (8) , 1185-1198
Abstract
BACKGROUND: Mycophenolic acid (MPA) is a well-known inhibitor of inosine monophosphate dehydrogenases (IMPDH), and our previous study also highlighted its inhibitory effects on histone deacetylases (HDACs). This study aims to evaluate MPA as a potential regulator of cell differentiation and to explore its mechanisms as an inhibitor of IMPDHs and HDACs using tonsil-derived mesenchymal stem cells (TMSCs). METHODS: TMSCs were treated with MPA at various concentrations for 48 h to evaluate its cytotoxic effects. The MPA treatment conditions were then optimized to induce differentiation of TMSCs. To investigate the underlying mechanisms, protein levels of IMPDH, HDAC3 and the histone acetyltransferase p300 (EP300) were assessed. RESULTS: MPA even at the highest concentration (160 μM) showed strong cytostatic effects on TMSCs without inducing cell death. Pre-treatment with 10 μM MPA for 48 h promoted osteogenic differentiation while inhibiting adipogenic differentiation. IMPDH inhibition via siRNA mimicked these effects, increasing calcium mineralization in the differentiated TMSCs. Co-treatment with guanosine reversed these effects, highlighting guanine depletion as a key mechanism of inducing osteogenesis. MPA also reduced the protein levels of HDAC3 and histone acetyltransferase p300 (EP300), which were also reversed by guanosine supplementation. The knockdown of HDAC3 or EP300 using siRNAs enhanced osteogenesis, with guanosine reversing these effects. HDAC3 overexpression reversed the effects of MPA, decreasing calcium mineralization. CONCLUSION: These findings suggest that MPA induces osteogenesis through guanine depletion, and that subsequent inhibition of HDAC3 and EP300 could be potential strategies for treating bone diseases.Keywords
Funding Information
- National Research Foundation of Korea (2018R1D1A1A02085696)
- Korean Fund for Regenerative Medicine (23B0101L1)
This publication has 49 references indexed in Scilit:
- CA1 Modulates the Osteogenic Differentiation of Dental Follicle Stem Cells by Activating the BMP Signaling Pathway In VitroTissue Engineering and Regenerative Medicine, 2024
- Therapeutic Effect of HDAC5 Binding and Cell Penetrating Peptide for the Treatment of Inflammatory Bowel DiseaseTissue Engineering and Regenerative Medicine, 2023
- Application of Tonsil-Derived Mesenchymal Stem Cells in Tissue Regeneration: Concise ReviewStem Cells, 2019
- HDAC8, A Potential Therapeutic Target, Regulates Proliferation and Differentiation of Bone Marrow Stromal Cells in Fibrous DysplasiaStem Cells Translational Medicine, 2018
- Regulation of osteogenesis of human amniotic mesenchymal stem cells by sodium butyrateCell Biology International, 2017
- Mycophenolic acid potentiates HER2-overexpressing SKBR3 breast cancer cell line to induce apoptosis: involvement of AKT/FOXO1 and JAK2/STAT3 pathwaysApoptosis, 2016
- Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cellsPediatric Nephrology, 2016
- Exposure to Penicillium mycotoxins alters gene expression of enzymes involved in the epigenetic regulation of bovine macrophages (BoMacs)Mycotoxin Research, 2013
- The Changing Balance Between Osteoblastogenesis and Adipogenesis in Aging and its Impact on HematopoiesisCurrent Osteoporosis Reports, 2013
- Mycophenolate Mofetil Has Potent Anti-inflammatory Actions in a Mouse Model of Acute Lung InjuryInflammation, 2013